• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • NORTH AMERICA EDITION
      Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • NORTH AMERICA EDITION
      North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Technology Market
    Technology News
    Technology Stocks
    • Technology Market
    • Technology News
    • Technology Stocks

    Leonovus Closes $1.5 Million Financing to Fuel Blockchain Strategy

    Jocelyn Aspa
    Sep. 22, 2017 09:43AM PST
    Technology Investing News

    LeoNovus (TSXV:LTV) has announced it has closed a $1.5 million financing by way of a non-brokered private placement for 30 million units of the company at $0.05 per unit. As quoted in the press release:  Each Unit is one common share in the capital of the Company (a “Common Share”) and one Common Share Purchase …

    LeoNovus (TSXV:LTV) has announced it has closed a $1.5 million financing by way of a non-brokered private placement for 30 million units of the company at $0.05 per unit.
    As quoted in the press release:

     Each Unit is one common share in the capital of the Company (a “Common Share”) and one Common Share Purchase Warrant.  Each Warrant is exercisable into one Common Share at a price of CDN$0.075per Common Share for eighteen (18) months from the closing date of the Offering. The TSXV granted conditional approval for this financing on September 19, 2017.
    “The proceeds will be allocated towards working capital, sales and a significant amount of the proceeds towards our Blockchain initiatives to enhance our powerful security and compliance solution for bulk and archival data, which makes the total Leonovus solution even more attractive to our customers,” said Michael Gaffney, Chairman, and CEO.
    In connection with the Offering, the Company will pay cash finder’s fees of seven percent (7%) of the principal amount of funds raised, and will issue Broker Units in an amount of seven (7%) of the number of Units issued. Each Broker Unit is exercisable for a period of eighteen (18) months from the closing date of the Offering for the purchase of one Unit of the Company at a price of $0.05. Each Unit has the same terms as the Units in the Offering.

    Click here to read the full press release.

    private placement
    The Conversation (0)

    Go Deeper

    AI Powered
    Stallion Uranium Completes Second and Final Tranche of Oversubscribed $15,000,000 Non-Brokered Private Placement

    Stallion Uranium Completes Second and Final Tranche of Oversubscribed $15,000,000 Non-Brokered Private Placement

    Stallion Uranium Completes First Tranche of Non-Brokered Private Placement and Announces Upsizing

    Stallion Uranium Completes First Tranche of Non-Brokered Private Placement and Announces Upsizing

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×